Drug intelligence / Profile preview

TLR4 neutralizing antibody

Development stage
Preclinical
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous
01

Overview

A TLR4 neutralizing antibody is a type of monoclonal antibody designed to bind to Toll-like Receptor 4 (TLR4) and block its activation by ligands such as lipopolysaccharide (LPS) or endogenous damage-associated molecular patterns (DAMPs) like heme. TLR4 is a key component of the innate immune system, and its overactivation is implicated in various inflammatory conditions, sepsis, and vascular disorders. In research settings, these antibodies are used to elucidate the role of TLR4 signaling in processes like platelet activation and mitochondrial reactive oxygen species (mtROS) production. Several specific TLR4-targeting antibodies have entered clinical development for indications including sepsis, rheumatoid arthritis, and neuropathic pain.

Other names
anti-TLR4 antibodyanti-TLR-4 antibodyanti-TLR 4 antibodyTLR4 inhibitor antibodyTLR-4 inhibitor antibodyTLR 4 inhibitor antibodyTLR4-neutralizing mAbTLR-4-neutralizing mAbTLR 4-neutralizing mAb
02

Targets

FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on TLR4 neutralizing antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLR4 neutralizing antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call